10 Healthcare M&A Deals Transacted in Q3 2022

Commentary by: Eric Murphy, Managing Director, Global Healthcare Services

In the third quarter, Kauffman Hall reported 10 healthcare M&A transactions in its “Healthcare M&A Activity Report: Q3 2022.” One of the major transactions announced was Pure Health’s $500 million minority equity investment in Ardent Health Services. The smaller/acquired party size averaged $834 million, up from $619 million for yearend 2021. We are continuing to see the same trend of fewer transactions overall, while the transactions that are occurring remain at all-time high revenues.

Transaction Spotlight:

The largest transaction in the third quarter was UChicago Medicine’s affiliation with AdventHealth, which will increase services, treatment options and clinical trials for residents in Chicago’s western suburbs. UChicago Medicine will acquire controlling interest in AdventHealth’s Great Lakes region, which includes four hospitals. The partnership with UChicago Medicine, an academic medical institution, will enhance subspecialty care and capabilities for multidisciplinary services in the western Chicago communities.


Source: Kaufman, Hall & Associates, LLC

All information contained in this publication is derived from sources that are deemed to be reliable. However, Newmark has not verified any such information, and the same constitutes the statements and representations only of the source thereof, and not of Newmark. Any recipient of this publication should independently verify such information and all other information that may be material to any decision that recipient may make in response to this publication, and should consult with professionals of the recipient's choice with regard to all aspects of that decision, including its legal, financial, and tax aspects and implications. Any recipient of this publication may not, without the prior written approval of Newmark, distribute, disseminate, publish, transmit, copy, broadcast, upload, download, or in any other way reproduce this publication or any of the information it contains. This document is intended for informational purposes only and none of the content is intended to advise or otherwise recommend a specific strategy. It is not to be relied upon in any way to predict market movement, investment in securities, transactions, investment strategies or any other matter.

Download Our

Sign Up for Our Newsletter